Through a series of case studies, this slide deck considers the evidence linking key risk factors to elevated Lp(a) (ethnicity, genetics, menopause, kidney diseases, thyroid disease) and, in the absence of specific Lp(a) targeting agents, the guidelines-based risk management recommendations for patients in high Lp(a) risk groups.
Lilly has provided arms’ length sponsorship funding for the Lp(a) Forum Back to Basics Educational Resources but has had no influence or control over the content.
